InvestorsHub Logo

genisi

11/02/13 2:48 PM

#169181 RE: oc631 #169171

Some Data from LONESTAR-2 study in GT2/3 patients treated with Sofo/Peg/Riba (and also sofosbuvir + ledipasvir) will be presented at AASLD